Murae Organisor Ltd - Stock Valuation and Financial Performance

BSE: 542724 | NSE: | Pharmaceuticals & Drugs | Small Cap

Murae Organisor Share Price

1.54 0.04 2.67%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on Murae Organisor

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Murae Organisor stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
104.6 Cr.
52-wk low:
1
52-wk high:
3.1

Is Murae Organisor Ltd an attractive stock to invest in?

1. Is Murae Organisor Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Murae Organisor Ltd is a average quality company.

2. Is Murae Organisor Ltd undervalued or overvalued?

The key valuation ratios of Murae Organisor Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Murae Organisor Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Murae Organisor Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Murae Organisor:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Murae Organisor Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 17.1%22%24.9%24%17.4%4.2%12.3%11.7%0.8%-
Value Creation
Index
0.20.60.80.70.2-0.7-0.1-0.2-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 18.623.335.450.755.141.121152.51
Sales YoY Gr.-25.7%51.8%43.1%8.7%-25.5%-48.8%-28.9%-83%-
Adj EPS 0.10.10.20.30.300.30.300
YoY Gr.-33.3%125%83.3%-24.2%-96%3000%-12.9%-100%-
BVPS (₹) 0.80.90.91.2222.32.62.32.2
Adj Net
Profit
0.10.10.91.71.80.12.220.10
Cash Flow from Ops. -0.30.1-7.1-0.5-3.5-7.12.60.3-15.9-
Debt/CF from Ops. -7.224.1-1-20-2.7-1.63.433.30-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA-45.1%-60.5%-83%
Adj EPS NA-100%-100%-100%
BVPSNA14.3%4.3%-11.7%
Share Price - -19.3% -49.1% 52.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
7.49.92830.817.90.614.311.20.10
Op. Profit
Mgn %
2.81.74.46.52.3-18.9-2111.9-44.2-107
Net Profit
Mgn %
0.60.62.53.33.30.210.613.32.10
Debt to
Equity
1.41.41.71.60.60.80.50.50-
Working Cap
Days
01491551511822644796879,7763,146
Cash Conv.
Cycle
07189961122054435923,2562,838

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 0.00%

Sales growth has been subdued in last 3 years -60.46%

Sales growth is not so good in last 4 quarters at -86.58%

Latest Financials - Murae Organisor Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 1.1 -
BVPS (₹.) 2.2 -
Reserves (₹ Cr.) 15 -
P/BV 0.68 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.98 / 3.10
All Time Low / High (₹) 0.90 / 22.31
Market Cap (₹ Cr.) 105
Equity (₹ Cr.) 139.4
Face Value (₹) 2
Industry PE 43

Management X-Ray of Murae Organisor:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Murae Organisor

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales19233551554121153
Operating Expenses 18233447544925134
Manufacturing Costs000000000
Material Costs17223346504625123
Employee Cost 000000000
Other Costs 111132011
Operating Profit 10231-8-42-1
Operating Profit Margin (%) 2.8%1.7%4.4%6.5%2.2%-18.9%-21.0%11.9%-44.2%
Other Income 000029812
Interest 011111000
Depreciation 000000000
Exceptional Items 000000000
Profit Before Tax 001220330
Tax 000110110
Profit After Tax 001220220
PAT Margin (%) 0.5%0.7%2.6%3.3%3.3%0.2%10.6%13.3%2.1%
Adjusted EPS (₹)0.00.10.20.30.30.00.30.30.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 12461415171956
Share Capital 000066121249
Reserves 114688466
Minority Interest000000000
Debt2278811990
Long Term Debt011312000
Short Term Debt215679990
Trade Payables55771211-10
Others Liabilities 1322212264
Total Liabilities 911202336282929120

Fixed Assets

Gross Block000111111
Accumulated Depreciation000000001
Net Fixed Assets000011100
CWIP 000000000
Investments 000030000
Inventories478111315121312
Trade Receivables441111171115811
Cash Equivalents 0000000012
Others Assets0101211785
Total Assets 911202336282929120

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 00-70-3-730-16
PBT 001220330
Adjustment 000111000
Changes in Working Capital -1-1-8-2-5-70-2-17
Tax Paid 000-1-10-1-11
Cash Flow From Investing Activity 0000-33000
Capex 000000000
Net Investments 0000-30000
Others 000003000
Cash Flow From Financing Activity 107173-3028
Net Proceeds from Shares 0020700037
Net Proceeds from Borrowing 1011-11-200
Interest Paid 000000000
Dividend Paid 000000000
Others 00401200-9
Net Cash Flow 00000-10012
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)7.1511.0530.9432.1717.830.6114.2411.180.14
ROCE (%)17.121.9724.9423.9917.44.2312.3411.660.81
Asset Turnover Ratio2.112.352.322.371.861.280.740.520.03
PAT to CFO Conversion(x)N/AN/A-70-1.5N/A1.50N/A
Working Capital Days
Receivable Days88637478921232232861,373
Inventory Days71797669811282403101,817
Payable Days1078366556651184-52

Murae Organisor Ltd Stock News

Murae Organisor Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Murae Organisor on 21-Nov-2024 16:59 is ₹1.54.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Murae Organisor stood at ₹104.6.
The latest P/E ratio of Murae Organisor as of 21-Nov-2024 16:59 is 0.00.
The latest P/B ratio of Murae Organisor as of 21-Nov-2024 16:59 is 0.68.
The 52-week high of Murae Organisor is ₹3.10 and the 52-week low is ₹0.98.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Murae Organisor is ₹1.06 ( Cr.) .

About Murae Organisor Ltd

Earum Pharmaceuticals

Earum Pharmaceuticals was originally incorporated as 'Earum Pharmaceuticals Private Limited' on July 26, 2012 vide Registration no. 071299 under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Further, pursuant to Special Resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 10, 2019, the company was converted into a Public Limited Company and consequently the name of the Company was changed from 'Earum Pharmaceuticals Private Limited' to 'Earum Pharmaceuticals Limited' vide a fresh Certificate of Incorporation dated January 23, 2019 issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company post conversion.

Business area of the company

The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections.  Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API’s) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc.

Milestones:
2012: Incorporation of the Company in the name of 'Earum Pharmaceuticals Private Limited'.
2014-15: Total turnover of the Company reached to Rs. 8 crores.
2015-16: Crossed Turnover of Rs. 18 crores.
2016-17: Crossed Turnover of Rs. 23 crores.
2017-18: Crossed Turnover of Rs. 35 crores.
2019: Conversion of the Company from Private Limited to Public Limited Company.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.